Stem Cell Therapy for COPD
Clinical trials for patient advance and scientific experiments progress with empirical evidence and findings toward clinical use for patients. Stem Cell Therapy for Chronic Obstructive Pulmonary Disease (COPD) has been practiced outside of the USA. It is a plausible treatment available overseas for patients with (COPD). The FDA has not approved this treatment within or outside of the USA.
COPD is a disease that affects the lungs, causing difficulty in breathing and poor airflow to patients. It can gradually worsen over time and typically impacts people over age 40. Smoking is the most common cause of this disease. Whereas a bronchodilator may help patients with asthma, it is not effective for COPD patients.
Until recently the medical community could not indicate any progress for COPD. Many patients would be prescribed medications that would calm some symptoms while bringing adverse side effects to patients. There have been many clinical studies in recent years and many more patients are in clinical trials testing stem cell therapy for COPD as a future option.
Stem cell therapy has shown, in scientific trials on patients, how the treatment gives a plausible solution to families struggling with this condition. The latest research demonstrates that patients with COPD may be helped using stem cell therapy and/or a combination of treatments and medications.
You will find data here from clinical trials. We invite you to see further details about this treatment from overseas clinics that have already treated many patients and show results.
Stem cell therapy has been practiced overseas for years and may bring positive outcomes to families dealing with COPD. You will find on our website clinics that use this treatment and you can schedule an appointment with them.
Please contact us so we may inform you on a clinical trial relevant to your needs. Watch this space as we continue to present scientific findings and medical innovations from this field of medicine. Know that this therapy is not yet approved by the FDA.
Stem Cell Therapy Adoption
Data obtained from Clinical Trials